Biosensors & POCT– category –
-
Roche Unveils AXELIOS 1 Next-Gen Sequencing Platform and cobas® Mass Spec at ADLM 2026, Addressing Lab Workforce & Workflow Challenges
PR Newswire (via Roche) Switzerland Overview Roche showcased advanced integrated diagnostic solutions at ADLM 2026, featuring the new AXELIOS 1 next-generation sequencing platform and cobas® Mass Spec solution. These innovations aim to e... -
UT Southwestern Develops Novel Biosensor to Track α-Ketoglutarate, Unraveling Mechanisms of Severe Childhood Brain Disorder and Suggesting Early Intervention
UT Southwestern Medical Center USA Overview Researchers at UT Southwestern's Children's Medical Center Research Institute have developed a novel biosensor capable of tracking alpha-ketoglutarate (αKG), a critical metabolite. Published in... -
Roche Reports 6% H1 2026 Sales Growth, Secures CE Marks for New Alzheimer’s and TB Blood Tests, Acquires AI Pathology Firm PathAI
Roche (Official Press Release), Fierce Biotech Switzerland Overview Roche reported robust 6% sales growth in H1 2026 at constant exchange rates, with diagnostics contributing 3% despite healthcare price reforms in China. Key advancements... -
Dexcom Selected as First Participant in FDA’s TEMPO Pilot Program to Advance AI-Powered Glucose Health for Early Prediabetes & T2D Intervention
Business Wire (via Dexcom Investor Relations) USA Overview Dexcom has been selected as the inaugural participant in the FDA's TEMPO (Technology-Enabled Meaningful Patient Outcomes) digital health devices pilot program, aiming to accelera... -
Lidsen Paper Details Advances in Gold Nanoparticles-Based Colorimetric Assays Using Aptamers for Rapid Food Detection
Lidsen International Overview Research published in Lidsen discusses advancements in gold nanoparticles-based colorimetric assays using aptamers for rapid food detection. It emphasizes how aptamers, as biorecognition elements, combined w... -
bioRxiv: SMART-NeuroDx Achieves Reagent-Free, ML-Driven 4-Analyte Dementia Screening with LoD of 0.087 pg/mL
bioRxiv USA Overview A preprint published on bioRxiv on July 23, 2026, describes SMART-NeuroDx, a reagent-free multianalyte biosensor platform with machine-learning (ML) readout. Aimed at point-of-care dementia screening, this platform a... -
MDPI Review: Electrochemical Aptamer Sensors Revolutionize In Vivo Pharmacokinetic Monitoring of Anthracycline Chemotherapeutics
MDPI (Biosensors) Switzerland Overview A review in MDPI's Biosensors discusses the mechanisms, stability, and clinical translation landscape of electrochemical aptamer-based (EAB) sensors for in vivo pharmacokinetic monitoring of anthrac... -
FDA Selects Dexcom as First Participant in ‘TEMPO’ Digital Health Pilot Program
MedTech Dive USA Overview The FDA has selected Dexcom as the first participant in its new Technology-Enabled Meaningful Patient Outcomes (TEMPO) Pilot Program. This pilot will enable Dexcom to implement an AI-enabled glucose health progr... -
STYRKR Showcases Flowbio and HDrop Wearable Sweat Sensors, Enhancing Athletic Performance Through Real-time Sweat Composition Analysis
STYRKR UK Overview STYRKR has showcased wearable sweat sensors like Flowbio and HDrop, designed to enhance athletic performance. These devices utilize microfluidic channels to track sweat rate and sodium loss in real-time, syncing to an ... -
Novagard Ensures Biocompatibility of Wearable Biosensors with ISO 10993 Compliant Medical-Grade Silicones
Novagard USA Overview Novagard designs and manufactures silicone solutions for medical devices, specifically wearable biosensor patches that continuously collect signals like ECG, body temperature, motion, respiration, glucose, and sweat...
